Researchers have developed a groundbreaking protocol to create functional acinar cells within organoids, offering a novel approach to understanding pancreatic development and cancer. But here's where it gets controversial: the team's findings challenge traditional beliefs about acinar cell differentiation, sparking debates among experts. Acinar cells, once thought to be a main contributor to pancreatic cancer, have now been successfully developed with unprecedented functionality in a human pancreas organoid.
Organoids, miniature models of organs grown in a dish, have revolutionized research in human development, organ regeneration, and disease progression. By engineering patient tissues or cells, researchers can study the impact of specific proteins and their variants. However, current methods for analyzing multiple genes simultaneously have limitations, failing to capture the intricate changes in cell shape and movement in response to genetic and molecular alterations. High-content image-based screens offer a solution, but their implementation and analysis present challenges.
The research team, led by Anne Grapin-Botton at the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) in Dresden, Germany, and also an honorary professor at TU Dresden, along with the MPI-CBG Technology Development Studio, has developed a system to simultaneously test numerous compounds using pancreatic organoids composed of human pancreatic progenitor cells. Through high-content image-based screening and quantitative multivariate analysis, they identified compounds affecting cell identity and organoid shape, particularly inhibitors of the GSK3A/B protein. When this protein is inhibited, the WNT signaling pathway is activated, leading to the expression of genes found in acinar cells. However, the cells did not fully differentiate into acinar cells, prompting the researchers to optimize the growth medium.
The team observed that removing the growth factor FGF led to further differentiation and the formation of rosette-like structures, a characteristic of acinar cells in living organisms. With electron microscopy, they found tiny vesicles inside the cells, a typical feature of enzyme-producing pancreatic acinar cells. They then tested the functionality of these acinar cells, confirming their production of enzymes like amylase and trypsin, crucial for digestion. This achievement marks a significant step forward in our understanding of pancreas development and may lead to the discovery of new therapeutic targets for pancreatic cancer.
The researchers plan to further assess human pancreatic cancer initiation using their system, inviting discussion and debate among the scientific community. This study not only advances our knowledge of pancreas development but also opens up new possibilities for cancer research and treatment.
